Patents by Inventor James N. Kenealy

James N. Kenealy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MID-GINGIVAL IMPLANT SYSTEM
    Publication number: 20190350683
    Abstract: The present invention provides a mid-gingival dental implant system that includes a dental implant having a threaded body portion and a superstructure extending from a coronal surface of the threaded body portion. The superstructure includes two O-ring housings for housing deformable O-rings. The mid-gingival system can also include two screws. One for screw retained final components and one for cement retained final components.
    Type: Application
    Filed: May 17, 2019
    Publication date: November 21, 2019
    Inventors: James N. Kenealy, Dan P. Rogers, Esther Moran
  • Transdermal administration of azapirones
    Patent number: 5837280
    Abstract: In accordance with the present invention, a method and device is provided for administering therapeutically effective doses of the drug azospirone transdermally for treating psychogenic symptomatologies. One embodiment of the present invention comprises an effective amount of solubilized azospirone in a transdermal drug delivery device. By practicing the present invention, constant blood concentrations of azospirone can be maintained over a prolonged period of time, side effects can be minimized with maximal patient compliance.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: November 17, 1998
    Assignee: Sano Corporation
    Inventors: James N. Kenealy, Cheryl M. Gentile
  • Transdermal administration of azapirones
    Patent number: 5817331
    Abstract: In accordance with the present invention, a method and device is provided for administering therapeutically effective doses of the drug azospirone transdermally for treating psychogenic symptomatologies. One embodiment of the present invention comprises an effective amount of solubilized azospirone in a transdermal drug delivery device. By practicing the present invention, constant blood concentrations of azospirone can be maintained over a prolonged period of time, side effects can be minimized with maximal patient compliance.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: October 6, 1998
    Assignee: Sano Corporation
    Inventors: James N. Kenealy, Cheryl M. Gentile
  • Transdermal administration of azapirones
    Patent number: 5633009
    Abstract: In accordance with the present invention, a method and device is provided for administering therapeutically effective doses of the drug azospirone transdermally for treating psychogenic symptomatologies. One embodiment of the present invention comprises an effective amount of solubilized azospirone in a transdermal drug delivery device. By practicing the present invention, constant blood concentrations of azospirone can be maintained over a prolonged period of time, side effects can be minimized with maximal patient compliance.
    Type: Grant
    Filed: November 12, 1993
    Date of Patent: May 27, 1997
    Assignee: Sano Corporation
    Inventors: James N. Kenealy, Cheryl M. Gentile